Your session is about to expire
← Back to Search
Other
Augmented Reality Tool for PICC Placement
N/A
Recruiting
Led By Ali H Dhanaliwala, MD, PhD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Over 18 years
Be older than 18 years old
Must not have
Younger than 18 years old
Undergoing an emergent peripherally inserted central catheter placement
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of procedure
Awards & highlights
No Placebo-Only Group
Summary
This trial tests special glasses with a virtual ruler to help doctors place medical tubes accurately in patients who need precise catheter placement.
Who is the study for?
This trial is for adults over 18 who are scheduled to have a non-emergency peripherally inserted central catheter (PICC) placed in Interventional Radiology. It's not for anyone under 18 or those needing an emergency PICC placement.
What is being tested?
The study is testing the use of an augmented reality virtual ruler to see if it can improve safety and clinical workflow during the placement of PICCs, which are used for long-term medication administration.
What are the potential side effects?
Since this trial involves a non-invasive tool (augmented reality ruler), there aren't direct side effects like with medications. However, there may be indirect issues related to incorrect PICC placement if the tool doesn't work as expected.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am over 18 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am under 18 years old.
Select...
I am getting a special IV line placed in my arm soon.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ end of procedure
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of procedure
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Number of participants with appropriate catheter tip location
Secondary study objectives
Procedure time
Radiation dose
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Augmented reality virtual rulerExperimental Treatment1 Intervention
Patient's in this arm will have their physician use an augmented reality virtual ruler to measure catheter length during catheter placement.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for Peripherally Inserted Central Catheter (PICC) placement emphasize precision and accuracy to minimize complications. The use of an Augmented Reality (AR) Virtual Ruler enhances these aspects by providing real-time visualization of the insertion point and trajectory.
This technology helps ensure the catheter is correctly positioned, reducing the risk of malposition, vessel injury, and infection. Accurate placement is essential for the catheter's proper function in medication delivery and overall patient safety.
Find a Location
Who is running the clinical trial?
University of PennsylvaniaLead Sponsor
2,084 Previous Clinical Trials
42,727,028 Total Patients Enrolled
Ali H Dhanaliwala, MD, PhDPrincipal InvestigatorUniversity of Pennsylvania
1 Previous Clinical Trials
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am under 18 years old.I am scheduled for a planned PICC line placement.I am over 18 years old.I am getting a special IV line placed in my arm soon.
Research Study Groups:
This trial has the following groups:- Group 1: Augmented reality virtual ruler
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.